Graham Collingridge

Graham Leon Collingridge FRS (born 1 February 1955) is a British neuroscientist[1] and professor at the University of Toronto and at the University of Bristol.[2][3] He is also a senior investigator at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital in Toronto.

Professor Collingridge’s research focuses on the mechanisms of synaptic plasticity in health and disease, in particular, understanding synaptic plasticity in molecular terms and how pathological alterations in these processes may lead to major brain disorders, such as Alzheimer’s disease. Professor collingridge was with Professors Tim Bliss and Richard Morris as the first UK scientists to share the Brain Prize, one of the world's most coveted science prizes.[4]

Life

Born 1 February 1955. Collingridge was educated at Enfield Grammar School and earned his undergraduate degree in Pharmacology from University of Bristol and a PhD from the School of Pharmacy (University of London). He was a postdoctoral fellow in the Department of Physiology at the University of British Columbia (Vancouver, Canada) and in the Department of Physiology and Pharmacology at the University of New South Wales (Sydney, Australia). In 1983 he was appointed to a lectureship at the Department of Pharmacology at the University of Bristol. From 1990 until 1994 he was the Departmental Chair in Pharmacology at the University of Birmingham (UK). In 1994 he returned to the University of Bristol as the Professor of Neuroscience in Anatomy. There he served as Departmental Chair of Anatomy (1997-1999) and then as the Director of the MRC Centre for Synaptic Plasticity (1999-2012).

Professor Collingridge has held visiting Professorships at the University of British Columbia and at Seoul National University. He served as Editor-in-Chief of Neuropharmacology from 1993 until 2010. In 1997 he was elected a Founder Fellow of the European DANA Alliance; and in 1998 he was elected a Founder Fellow of the Academy of Medical Sciences (UK). In 2001 he was elected a Fellow of The Royal Society, and from 2007 until 2009 he served as President of the British Neuroscience Association (BNA). He is currently the reviews editor for Molecular Brain and serves on the scientific advisory board of Hello Bio.

Graham Collingridge is the Ernest B. and Leonard B. Smith Professor and Chair of the Department of Physiology at the University of Toronto. He is also a Senior Investigator at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital in Toronto. Professor Collingridge also holds an appointment in the School of Physiology, Pharmacology and Neuroscience at the University of Bristol, UK.

Honours and Awards[5]

  1. 1992 Sharpey-Shafer Prize (The Physiological Society)
  2. 1997 Founder Fellow, European DANA Alliance
  3. 1998 Founder Fellow, Academy of Medical Sciences
  4. 2001 Elected Fellow, The Royal Society
  5. 2003 Gaddam Memorial Prize (The Pharmacological Society)
  6. 2007 President, British Neuroscience Association
  7. 2008 The Santiago Grisolia Prize
  8. 2013 The Feldberg Prize
  9. 2016 The Brain Prize, European Brain Research Foundation

References

  1. ↑ "Prof Graham Collingridge Authorised Biography – Debrett’s People of Today, Prof Graham Collingridge Profile". Debretts.com. Retrieved 2012-12-21.
  2. ↑ "Professor Graham Collingridge - Physiology and Pharmacology". Bristol.ac.uk. 2011-09-05. Retrieved 2012-12-21.
  3. ↑ "Bristol Neuroscience Directory". Bristol.ac.uk. 2011-01-13. Retrieved 2012-12-21.
  4. ↑ "'Nobel' prize of neuroscience awarded to three Britons". Mail Online. Retrieved 2016-03-02.
  5. ↑ "Biography Graham Collingridge - Grete Lundbeck European Brain Research Foundation". www.thebrainprize.org. Retrieved 2016-03-02.

External links

This article is issued from Wikipedia - version of the Friday, March 04, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.